Cumberland Pharmaceuticals Inc. (CPIX)

Market Cap	43.98M
Revenue (ttm)	42.07M
Net Income (ttm)	-2.93M
Shares Out	14.96M
EPS (ttm)	-0.21
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	46,706
Open	3.000
Previous Close	2.910
Day's Range	2.890 - 3.000
52-Week Range	1.040 - 7.250
Beta	-0.39
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 5, 2025

About CPIX

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, an injection for the prevention of nausea and vomiti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Aug 11, 2009
• Employees: 91
• Stock Exchange: NASDAQ
• Ticker Symbol: CPIX
• Website: https://www.cumberlandpharma.com

Financial Performance

In 2024, CPIX's revenue was $37.87 million, a decrease of -4.26% compared to the previous year's $39.55 million. Losses were -$6.48 million, 3.19% more than in 2023.